Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016

  • ID: 4043292
  • Company Profile
  • 57 pages
  • Global Markets Direct
1 of 4
Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016

Summary:

‘Kissei Pharmaceutical Co Ltd - Product Pipeline Review - 2016’, provides an overview of the Kissei Pharmaceutical Co Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Kissei Pharmaceutical Co Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Kissei Pharmaceutical Co Ltd
- The report provides overview of Kissei Pharmaceutical Co Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Kissei Pharmaceutical Co Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Kissei Pharmaceutical Co Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Kissei Pharmaceutical Co Ltd’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Kissei Pharmaceutical Co Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Kissei Pharmaceutical Co Ltd’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Introduction

Kissei Pharmaceutical Co Ltd Snapshot

Kissei Pharmaceutical Co Ltd Overview

Key Facts

Kissei Pharmaceutical Co Ltd - Research and Development Overview

Key Therapeutic Areas

Kissei Pharmaceutical Co Ltd - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Kissei Pharmaceutical Co Ltd - Pipeline Products Glance

Kissei Pharmaceutical Co Ltd - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Kissei Pharmaceutical Co Ltd - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Kissei Pharmaceutical Co Ltd - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Kissei Pharmaceutical Co Ltd - Drug Profiles

AS-192426900 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

AS-192781900 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

AS-193280400 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

bedoradrine sulfate - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

KDT-3594 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

KLH-2109 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

KSI-6666 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

KTA-439 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

mitiglinide - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

ozagrel - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

remogliflozin etabonate - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

rovatirelin - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule to Inhibit SGLT1 for Postprandial Hyperglycemia - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

YS-110 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Kissei Pharmaceutical Co Ltd - Pipeline Analysis

Kissei Pharmaceutical Co Ltd - Pipeline Products by Target

Kissei Pharmaceutical Co Ltd - Pipeline Products by Route of Administration

Kissei Pharmaceutical Co Ltd - Pipeline Products by Molecule Type

Kissei Pharmaceutical Co Ltd - Pipeline Products by Mechanism of Action

Kissei Pharmaceutical Co Ltd - Dormant Projects

Kissei Pharmaceutical Co Ltd - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

diquafosol tetrasodium

KEA-0477

KGA-3235

KLS-0611

KUX-1151

neflamapimod

remogliflozin etabonate

ritobegron

sergliflozin

Kissei Pharmaceutical Co Ltd - Company Statement

Kissei Pharmaceutical Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Kissei Pharmaceutical Co Ltd, Key Facts

Kissei Pharmaceutical Co Ltd - Pipeline by Indication, 2016

Kissei Pharmaceutical Co Ltd - Pipeline by Stage of Development, 2016

Kissei Pharmaceutical Co Ltd - Monotherapy Products in Pipeline, 2016

Kissei Pharmaceutical Co Ltd - Partnered Products in Pipeline, 2016

Kissei Pharmaceutical Co Ltd - Partnered Products/ Combination Treatment Modalities, 2016

Kissei Pharmaceutical Co Ltd - Out-Licensed Products in Pipeline, 2016

Kissei Pharmaceutical Co Ltd - Out-Licensed Products/ Combination Treatment Modalities, 2016

Kissei Pharmaceutical Co Ltd - Pre-Registration, 2016

Kissei Pharmaceutical Co Ltd - Phase III, 2016

Kissei Pharmaceutical Co Ltd - Phase II, 2016

Kissei Pharmaceutical Co Ltd - Phase I, 2016

Kissei Pharmaceutical Co Ltd - Preclinical, 2016

Kissei Pharmaceutical Co Ltd - Pipeline by Target, 2016

Kissei Pharmaceutical Co Ltd - Pipeline by Route of Administration, 2016

Kissei Pharmaceutical Co Ltd - Pipeline by Molecule Type, 2016

Kissei Pharmaceutical Co Ltd - Pipeline Products by Mechanism of Action, 2016

Kissei Pharmaceutical Co Ltd - Dormant Developmental Projects,2016

Kissei Pharmaceutical Co Ltd - Discontinued Pipeline Products, 2016

Kissei Pharmaceutical Co Ltd, Other Locations

Kissei Pharmaceutical Co Ltd, Subsidiaries

List of Figures:

Kissei Pharmaceutical Co Ltd - Pipeline by Top 10 Indication, 2016

Kissei Pharmaceutical Co Ltd - Pipeline by Stage of Development, 2016

Kissei Pharmaceutical Co Ltd - Monotherapy Products in Pipeline, 2016

Kissei Pharmaceutical Co Ltd - Partnered Products in Pipeline, 2016

Kissei Pharmaceutical Co Ltd - Out-Licensed Products in Pipeline, 2016

Kissei Pharmaceutical Co Ltd - Pipeline by Top 10 Target, 2016

Kissei Pharmaceutical Co Ltd - Pipeline by Route of Administration, 2016

Kissei Pharmaceutical Co Ltd - Pipeline by Molecule Type, 2016

Kissei Pharmaceutical Co Ltd - Pipeline Products by Top 10 Mechanism of Action,
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll